Cardano could hit $5 by 2025 for a 5x gain, but Layer Brett’s $0.0058 presale, 700%+ APY staking, and 100x upside potential make it the clear high-growth play.Cardano could hit $5 by 2025 for a 5x gain, but Layer Brett’s $0.0058 presale, 700%+ APY staking, and 100x upside potential make it the clear high-growth play.

Cardano Price Prediction 2025 – 2030: ADA Price Could top $5 But Experts Suggest This Meme Coin Could 100x

cardano64587 LBR

The talk around Cardano price predictions has been heating up again, with some analysts suggesting Cardano could climb as high as $5 by 2025. While that may sound appealing, the reality is that such gains would take years and offer little upside compared to newer projects. In fact, a growing number of retail traders and crypto experts are shifting attention to Layer Brett (LBRETT) —a meme-powered Ethereum Layer 2 project that has already raised nearly $3.7 million in its presale and is fast racing toward the $4 million milestone. With prices still just $0.0058 and staking rewards over 700% APYs, the opportunity here looks far more explosive than Cardano’s slow grind higher.

Cardano (ADA) price prediction: Is $5 a realistic goal?

At around the $0.88 range, Cardano is trying to maintain momentum, with bulls pointing to a potential 15% bump in September and a longer-term climb toward $5 by 2025. But let’s break that down: a move from $0.90 to $5 is roughly a 5x gain, spread out over several years. For early investors that might look decent, but in today’s crypto market, a 5x over half a decade barely moves the needle. Cardano has long been known for big promises about scalability and DeFi adoption, yet its track record has been plagued by slow development and underwhelming real-world usage.

Yes, Cardano has built a reputation on being “sustainable” and “future-proof,” but for everyday investors, it feels more like watching paint dry. The hype around Cardano being the “Ethereum killer” has faded, and despite upgrades, its parabolic days appear to be behind it. In short, even if Cardano does touch $5, most retail traders chasing life-changing gains won’t find them there.

lbr

Why Layer Brett (LBRETT) offers real parabolic upside

This is where Layer Brett separates itself. Unlike Cardano, which crawls forward with incremental gains, LBRETT is designed for explosive growth. Built as a robust Ethereum Layer 2 protocol, it combines the viral energy of a meme token with the scalability and low fees of a cutting-edge blockchain solution. Transactions are lightning-fast and ultra-cheap, anchored to Ethereum for security but processed off-chain for speed.

Early buyers aren’t just getting in on another meme coin—they’re getting access to a fully functional ecosystem with gamified staking, NFT integration, and transparent tokenomics built around a fixed supply of 10 billion tokens. At just $0.0058 per token, even a modest climb to $1 would mean nearly 200x returns for presale buyers, dwarfing anything Cardano could realistically offer.

The verdict: old guard vs new opportunity

Cardano price predictions aside, the math doesn’t lie: a potential move to $5 is small compared to what Layer Brett offers. With the presale on the verge of breaking past $3.7 million and surging toward $4 million, momentum is already here. Add in staking rewards of 700%+ APYs and a meme-fueled community ready to send this token viral, and it’s no wonder new investors are calling Layer Brett the top candidate for the next 100x in crypto.

Layer Brett is still in presale, but not for long. With a launch price under a penny and growth potential that eclipses the likes of Cardano, this may be the last great entry point before the 2025 bull run kicks into high gear.

LBRETT is available now at $0.0058. Don’t miss out on the next 100x—join the Layer Brett presale today.

Website: https://layerbrett.com

Telegram: https://t.me/layerbrett

X: Layer Brett (@LayerBrett) / X

lbrett banner

This article is not intended as financial advice. Educational purposes only.

Market Opportunity
PlaysOut Logo
PlaysOut Price(PLAY)
$0,09216
$0,09216$0,09216
+%4,02
USD
PlaysOut (PLAY) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26